Mikhail Blagosklonny is at Roswell Park Cancer Institute, and he serves there as Professor of Oncology. He has done research and comes up with final recommendation on how to treat cancer and rejuvenate skin. He attended the First Pavlov State Medical University of St Petersburg and got his MD in Internal Medicine. He then got his Ph.D. in Experimental Medicine and Cardiology from the same institution.
In his career, he started off as an associate professor of medicine at New York Medical College, Valhalla, New York. Mikhail then went to work at Ordway Research Institute and served as a senior scientist. In Roswell Park Cancer Institute, he acted as a Professor of Oncology in the year 2009. His expertise from all these scientific environments has made him become a star and someone that adds value to society as an excellent professor. His fields of interest are; looking for anti-aging drugs, researching for targeted cancer therapies taking care of the healthy cells from being mutated and lastly biogerontology that gets into explaining why people age. View Mikhail’s profile in LinkedIn
His experience has made him an editor-in-chief of Oncotarget and Cell Cycle. Mikhail co-edits cancer biology and therapy. He is on the editorial board of the Cell Death and Differentiation. In his studies, he has come to the conclusion that regards TOR Signaling potential as having a role in cancer and aging. The medicine that he has come up with called Rapamycin is a drug that he believes can cure cancer and age precisely. He is so passionate about this drug, and he advocates the use of the drug by the old so that their immunity can be boosted.
As he does his research, he focuses on Cellular and molecular biology and clinical investigations. The topics that he usually deals with are as follows; cell cycle, apoptosis, signal transduction, oncogenesis, tumor suppressors, drug resistance, selective protection, mitosis and anticancer therapeutics.
Mikhail Blagosklonny is an author and has written on the aging hyperfunction theory, cell cyclotherapy and adding more important technology to chemotherapeutic engineering. He has a very careful approach to cancer and wishes that he will solve the menace that it has created. While researching on cancer, he has discovered that cancer and aging are close. He believes that there will be a cure for cancer using Rapamycin.
Read more: http://www.aging-us.com/article/100591/text
He has written more than 300 articles that he has researched on. Journals and book chapters have been written and published/printed under his name. On top all these, he is an associate editor in PLOS ONE, American Journal of Pathology and the International Journal of Cancer. Mikhail Blagosklonny has continued to show his commitment, and through this, he has managed to achieve a lot that will be helpful to the human race.